Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo

Chronic nodular prurigo (CNP) is a chronic dermatological disease characterized by the presence of chronic pruritus and pruritic nodular lesions. The aim of this study was to reach consensus among a group of experts based on a non-systematic literature review and an algorithm for the clinical diagno...

Full description

Bibliographic Details
Authors: de Frutos, JO, Baldrich, ES, Boixareu, MJT, Hita, JCA, Carrillo, JMC, Nart, IF, Menéndez, AF, Pinto, PH, Silvestre, JF
Format: article
Status:Published version
Publication Date:2024
Country:España
Institution:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repository:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p11013
Online Access:https://isabial.portalinvestigacion.com/publicaciones11013
https://www.actasdermo.org/es-pdf-S0001731024007105
Access Level:Open access
Keyword:Chronic nodular prurigo
Prurigo nodularis
Algorithm
Diagnosis
Pruritus
Consensus
Description
Summary:Chronic nodular prurigo (CNP) is a chronic dermatological disease characterized by the presence of chronic pruritus and pruritic nodular lesions. The aim of this study was to reach consensus among a group of experts based on a non-systematic literature review and an algorithm for the clinical diagnosis of CNP. The resulting algorithm is structured in 3 blocks: 1) early identification of the patient with a possible diagnosis of CNP; 2) diagnosis and assessment of CNP; and 3) categorization of CNP (identification of the underlying causes or associated We believe that this clinical algorithm can facilitate the correct diagnosis of patients with CNP. Additionally, it raises awareness on the need for a multidisciplinary approach and specific treatment of CNP, steps of paramount importance to make better therapeutic decisions. (c) 2024 AEDV. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).